Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA.

The Journal of Rheumatology
Brendan B AntiochosWilliam F C Rigby

Abstract

To retrospectively evaluate the association of idiopathic inflammatory myopathy (IIM) and malignancy in patients seen at 1 academic center over a 23-year period. Patients were identified using the International Classification of Diseases, 9th edition (ICD-9) codes and diagnoses, then confirmed by chart review. Population cancer statistics obtained from the US Centers for Disease Control for Vermont and New Hampshire were used for comparison. Chart review confirmed IIM in 198 of 483 patients initially identified by ICD-9 codes. Within 5 years of diagnosis with IIM, malignancy developed in 32 patients (16.2%), 24 of whom (75%) had dermatomyositis (DM). Malignancy and DM developed within 1 year in 75%. The cancer risk associated with DM was much greater than the risk associated with other IIM. The most frequent tumor types were breast, lung, pancreas, and colon. DM patients with cancer were more frequently male and >or= 45 years of age than those without cancer. There were no cases of interstitial lung disease among patients with cancer and any form of IIM. The incidence of cancer was increased in patients with DM compared to age- and sex-matched population controls, both over a 5-year interval surrounding the diagnosis of DM and ...Continue Reading

References

Feb 13, 1975·The New England Journal of Medicine·A Bohan, J B Peter
Jan 1, 1976·Annals of Internal Medicine·B E Barnes, B Mawr
Feb 6, 1992·The New England Journal of Medicine·B SigurgeirssonE Allander
Aug 1, 1986·Mayo Clinic Proceedings·S LakhanpalL J Melton
Mar 1, 1980·Archives of Dermatology·J P CallenD R Kay
Jul 1, 1995·The Journal of Rheumatology·A AirioH Isomäki
Jan 1, 1995·Cancer Causes & Control : CCC·W H ChowJ F Fraumeni
Jan 1, 1993·The Journal of Investigative Dermatology·R L Euwer, R D Sontheimer
Mar 1, 1993·Pediatric Neurology·D D SherryJ M Milstein
Feb 18, 1998·International Journal of Dermatology·Y H Leow, C L Goh
May 8, 1998·Seminars in Arthritis and Rheumatism·C R MaozM Ehrenfeld
Oct 8, 1998·International Journal of Dermatology·W K FungW M Lam
Apr 12, 2001·The British Journal of Dermatology·Y J ChenJ L Shen
Nov 28, 2002·International Journal of Dermatology·Nobuo WakataMasao Kinoshita
Aug 13, 2003·Neurology·Anthony A Amato, Robert C Griggs
Aug 13, 2003·Neurology·M F G van der MeulenM de Visser
Mar 30, 2007·Annals of the Rheumatic Diseases·Hector ChinoyRobert G Cooper

❮ Previous
Next ❯

Citations

Feb 22, 2011·Current Rheumatology Reports·Zaki Abou Zahr, Alan N Baer
Jun 12, 2013·American Journal of Clinical Dermatology·Alisa N FemiaJeffrey P Callen
Feb 4, 2010·Nature Reviews. Rheumatology·Marinos C Dalakas
Sep 10, 2010·Current Opinion in Rheumatology·Albert Selva-O'CallaghanMoisés Labrador-Horrillo
May 18, 2011·Current Opinion in Pulmonary Medicine·Sai-Ching J YeungSonali N Thosani
Aug 18, 2012·Pulmonary Medicine·Kostas ArchontogeorgisDemosthenes Bouros
Dec 19, 2013·North American Journal of Medical Sciences·Patompong UngprasertChristine H Jones
Apr 29, 2010·Current Rheumatology Reports·Jeffrey P Callen
Feb 12, 2015·Modern Rheumatology·Shuzo SatoHiromasa Ohira
Mar 4, 2015·Chest·Tyler J AlbertJan V Hirschmann
Oct 6, 2012·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Takako Imai Tanaka, Shin-Mey Rose Y Geist
Nov 15, 2011·Rheumatic Diseases Clinics of North America·Rohit Aggarwal, Chester V Oddis
Jun 30, 2012·Dermatologic Therapy·Christina Lam, Ruth Ann Vleugels
Oct 3, 2015·Clinical Reviews in Allergy & Immunology·Eleni Tiniakou, Andrew L Mammen
Apr 19, 2016·Brain : a Journal of Neurology·Yves AllenbachOlivier Benveniste
Feb 15, 2015·Clinical Rheumatology·Jonathan Jones, Robert Wortmann
Jan 28, 2012·Biochemical and Biophysical Research Communications·Aki OgataYuichi Oike
Feb 28, 2015·American Journal of Clinical Dermatology·Jeannette M OlazagastiFloranne C Ernste
May 24, 2016·Clinical Rheumatology·Yao-Fan FangKuang-Hui Yu
Aug 19, 2016·Journal of Cutaneous Medicine and Surgery·Judy K QiangRaed Alhusayen
Jul 22, 2016·Anais Brasileiros De Dermatologia·Ana Cláudia Cavalcante EspositoHélio Amante Miot
Dec 3, 2014·The Journal of Rheumatology·Zaixing YangRenqian Zhong
Mar 19, 2013·The Journal of Rheumatology·Ilias N Lazarou, Pierre-André Guerne
Aug 19, 2016·Current Opinion in Neurology·Olivier BenvenisteYves Allenbach
Aug 6, 2013·The British Journal of Dermatology·J WangL Bao
Jan 1, 2021·Seminars in Arthritis and Rheumatism·Kun-Yan SunGuang-Fa Wang
Oct 24, 2020·Nature Reviews. Rheumatology·Yves AllenbachOlivier Boyer
Oct 1, 2010·Current Opinion in Rheumatology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.